Tumor-to-background ratio to predict response to chemotherapy of osteosarcoma better than standard uptake values. 来自 EBSCO 喜欢 0 阅读量: 93 作者:JP He,Y Hao,M Li,J Wang,FJ Guo 摘要: According to the current treatment protocol of the Cooperative Osteosarcoma Study, it is mandatory to ...
of Cy5 tagged aMMP2-SIP, indicated significantly lower tumor to background ratios at both 24 (P = 0.0090) and 48 h.p.i. (P < 0.0001) for the U87 MMP2-KD compared to control tumors. No differences were found for HT1080 and U373 models. U87 MMP2-KD tumors had ...
BACKGROUND Prostate cancer (PCa) frequently metastasizes to the bone and induces osteoblastic lesions. We previously demonstrated through over-expression o... CL Hall,SD Daignault,RB Shah,... - 《Prostate》 被引量: 249发表: 2010年 Multiparametric imaging of tumor response to therapy. There is ...
Six of the seven primary pulmonary tumors displayedin situfluorescence during resection while 1 displayed no fluorescence signal (Fig.3). Tumor fluorescence was only uniform in 2/6 canines; in the other 4 animals, surface fluorescence was irregular. The median Tumor to Background Fluorescent Ratio ...
Ground Truth Prediction 1-2) About This project is a segmentation model to diagnose brain tumor (Complete, Core) using BraTS 2016, 2017 dataset. BraTS has always been focusing on the evaluation of state-of-the-art methods for the segmentation of brain tumors in multimodal magnetic resonance...
Adenocarcinoma (NOS) of buccal mucosa metastasising to lung and frontal lobe of the brain: report of a rare case Background: Adenocarcinoma, not otherwise specified (ANOS), is a malignant salivary gland tumor that exhibits ductal differentiation but lacks any of the h... R Rajeev,VT Beena,...
Background: The prognostic significance of disseminated tumor cells (DTC) in bone marrow (BM) of breast cancer patients at the time of primary diagnosis ha... W Janni,FD Vogl,G Wiedswang,... - 《Clinical Cancer Research》 被引量: 274发表: 2011年 Population-Based Study of Contralateral Pr...
Background Immunotherapy, including checkpoint inhibition, has remarkably improved prognosis in advanced melanoma. Despite this success, acquired resistance is still a major challenge. The T cell costimulatory receptor TNFRSF9 (also known as 4-1BB and CD137) is a promising new target for immunotherap...
c Tumor-to-background ratios of fluorescence intensities (n = 5). CUDC-907 treatment significantly decreased tumor fibrosis as measured by whole-body luciferase activity. d CUDC-907 treatment significantly decreases tumor growth with or without fibroblasts mixture. e Masson’s trichrome staining ...
BACKGROUND: Recently, considerable efforts have been directed toward antivascular therapy as a new modality to treat human cancers. However, targeting a th... A Tandle,E Hanna,D Lorang,... - 《Cancer》 被引量: 47发表: 2015年 session v -dna transfer vehicles tumor-targeted gene delivery:...